UBE2I and ovarian cancer: Additionally, a strong correlation between UBC9 levels and drug resistance in ovarian cancer and acute lymphoblastic leukemia cell lines was observed, further supporting a role of UBC9-mediated SUMOylation in tumor drug responsiveness.